Literature DB >> 12429047

Differential dimerization and association among resistin family proteins with implications for functional specificity.

J Chen1, L Wang, Y S Boeg, B Xia, J Wang.   

Abstract

Secreted by white adipose tissue as a hormone, resistin was identified as a possible link between obesity and insulin resistance. High circulating resistin levels were observed to correlate with obesity. Administration of resistin lowered the glucose tolerance threshold and impaired insulin activity; whereas anti-resistin antibodies had the opposite effects. However, contradictory data were subsequently reported in regard to the correlation between resistin expression level and obesity or type 2 diabetes. Two additional proteins that share a highly homologous C-terminus with resistin have been identified in mouse, and one in human, forming a resistin-related protein family. Resistin was shown to dimerize through a disulfide bond formed by the N-terminal-most cysteine (Cys26). Here we demonstrate that while Cys26 is both necessary and sufficient for homodimer formation, all three resistin family members can also interact with one another regardless of the presence of Cys26 through non-covalent interactions. Furthermore, protein crosslinking analysis indicated that resistin and resistin beta, but not resistin alpha, exist as multimers, probably with a dimer as the subunit. The multiple protein complex formation is obviously at a level higher than the Cys26 disulfide bonding. These results suggest the potential importance of considering intermolecular interactions among resistin family members in studying their functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429047     DOI: 10.1677/joe.0.1750499

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow.

Authors:  N Shojima; T Ogihara; K Inukai; M Fujishiro; H Sakoda; A Kushiyama; H Katagiri; M Anai; H Ono; Y Fukushima; N Horike; A Y I Viana; Y Uchijima; H Kurihara; T Asano
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

Review 2.  Resistin: molecular history and prognosis.

Authors:  Ronadip R Banerjee; Mitchell A Lazar
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

Review 3.  Resistin: functional roles and therapeutic considerations for cardiovascular disease.

Authors:  Md S Jamaluddin; Sarah M Weakley; Qizhi Yao; Changyi Chen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity.

Authors:  Kee-Hong Kim; Ling Zhao; Yangsoo Moon; Chulho Kang; Hei Sook Sul
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-16       Impact factor: 11.205

5.  Mouse Resistin (mRetn): cloning, expression and purification in Escherichia coli and the potential regulative effects on murine bone marrow hematopoiesis.

Authors:  Fangyuan Wang; Jin Gao; Alyssa Malisani; Xiaowei Xi; Wei Han; Xiaoping Wan
Journal:  BMC Biotechnol       Date:  2015-11-16       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.